Bio-Rad Laboratories (BIO) Change in Acquisitions & Divestments (2010 - 2026)

Bio-Rad Laboratories (BIO) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $145.1 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments rose 644.1% year-over-year to $145.1 million in Q1 2026; TTM through Mar 2026 was $187.6 million, a 266.46% increase from a year earlier, with the FY2025 full-year figure at $62.0 million, down 68.89% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $145.1 million, up from $3.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for BIO reached as high as $774.1 million in Q3 2024 and fell as low as -$701.2 million in Q4 2024.
• Historically, Change in Acquisitions & Divestments has averaged $95.1 million across 5 years, with a median of $107.7 million in 2022.
• Across the five-year window, Change in Acquisitions & Divestments soared 4596.82% in 2022 and slumped 530.54% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $165.6 million in 2022, then slipped by 1.63% to $162.9 million in 2023, then slumped by 530.54% to -$701.2 million in 2024, then soared by 100.43% to $3.0 million in 2025, then surged by 4736.67% to $145.1 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $145.1 million in Q1 2026, $3.0 million in Q4 2025, and -$386.6 million in Q3 2025.